Cargando…
Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing
SIMPLE SUMMARY: Genotyping of BRCA genes is required for treatment with PARP inhibitors. Purposing to address treatment needs and familial cancer risk, the aim of our study was to introduce the most appropriate testing workflow in epithelial ovarian cancer patients (EOC) using germline and tumor gen...
Autores principales: | Stegel, Vida, Blatnik, Ana, Škof, Erik, Dragoš, Vita Šetrajčič, Krajc, Mateja, Gregorič, Brigita, Škerl, Petra, Strojnik, Ksenija, Klančar, Gašper, Banjac, Marta, Žgajnar, Janez, Ravnik, Maja, Novaković, Srdjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946582/ https://www.ncbi.nlm.nih.gov/pubmed/35326583 http://dx.doi.org/10.3390/cancers14061434 |
Ejemplares similares
-
Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes
por: Dragoš, Vita Šetrajčič, et al.
Publicado: (2022) -
Two Novel NF1 Pathogenic Variants Causing the Creation of a New Splice Site in Patients With Neurofibromatosis Type I
por: Setrajcic Dragos, Vita, et al.
Publicado: (2019) -
Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk
por: Strojnik, Ksenija, et al.
Publicado: (2021) -
New Approach for Detection of Normal Alternative Splicing Events and Aberrant Spliceogenic Transcripts with Long-Range PCR and Deep RNA Sequencing
por: Dragoš, Vita Šetrajčič, et al.
Publicado: (2021) -
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome
por: Blatnik, Ana, et al.
Publicado: (2022)